Federal Government backs ADHD prescribing consistency In response to last year’s Senate Inquiry, it also supports-in-principle calls to review relevant MBS items and pathways to GP assessments.
‘It’s completely filled my cup’: PRIDoC 2024 wraps up The Pacific Region Indigenous Doctors Congress was an opportunity for ‘transnational knowledge sharing and solidarity building’.
Mental health patients face record ED wait times With 10% of these patients now waiting 23 hours to be admitted, experts say this ‘logjam’ can be eased by early GP intervention.
RACGP celebrates practice managers at national conference The college used the event to ‘listen, discuss, and share’, highlighting the importance of the profession and learning what it needs.
RACGP fronts ADHD inquiry to fix system ‘serving no one’ An overhaul of Tasmania’s ADHD prescribing could be on the way, at a time when, the RACGP says, GPs are hamstrung by red tape and access barriers.
New ADHD prescribing guide launches The guide was designed to offer practical advice to GPs about safe and responsible prescribing, after finding significant variabilities.
GP named next AMA President Dr Danielle McMullen will take over the leadership in October and says her priority is advocating for greater investment into general practice.
ADHD med shortage set to end Supplies of lisdexamfetamine dimesilate should return to normal levels by the end of April, the TGA has advised.
The answer to psychiatric and child development waitlists Allowing trained GPs to initiate stimulant prescriptions for ADHD would help families and clinicians, writes Dr Andrew Leech.
Should ADHD medications be stopped during pregnancy? A new study found dexamphetamine does not put mothers or their babies at risk, but stopping before conception could be beneficial for some.